SYZYGY AG (SYZ)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 0.948 |
|---|---|
| 52-week range | 0.936 – 1.895 |
| Return, 1 month / 3 months | −16.8% / −25.1% |
| Return, 1 year / 3 years | −48.6% / −72.1% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 42.3% |
| Worst drawdown (1 year) | -49.3% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SYZYGY AG is a German digital agency group based in Bad Homburg that helps corporate clients with their online presence. Its teams design and build websites, run digital marketing campaigns, and develop e-commerce and mobile applications. The group serves brands and organisations across sectors such as retail, automotive and financial services, working from offices in several European cities. Its services cover strategy, creative work, technology and ongoing support for digital channels.
The shares are listed on the XETRA Stock Exchange in Germany under the code SYZ, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SYZYGY AG (SYZ) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 0.948 on 19 October 2026.
Its price-based Market X-Ray is 16 out of 100 (a weak price profile), ranking 650 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 48.6% and over the last three months it fell 25.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -27.2% | ||
| From 52-week high | -48.9% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -25.1% | ||
| 6-month return | -29.5% | ||
| 12-month return, skipping the last month | -38.2% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.3% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −7.1% |
|---|---|
| 1 month | −16.8% |
| 3 months | −25.1% |
| 6 months | −29.5% |
| 1 year | −48.6% |
| 3 years | −72.1% |
| 5 years | −82.1% |
Signals
| 50-day / 200-day average | 1.144 / 1.303 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.042 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jul 2023 | EUR 0.2200 |
| 6 Jul 2022 | EUR 0.2000 |
| 31 May 2021 | EUR 0.1500 |
| 10 Jun 2019 | EUR 0.1400 |
| 16 May 2019 | EUR 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.